These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 19913821

  • 1. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.
    MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, Siegel SW, Tate SB, Feagins BA.
    J Urol; 2010 Jan; 183(1):234-40. PubMed ID: 19913821
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.
    J Urol; 2009 Sep; 182(3):1055-61. PubMed ID: 19616802
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study.
    Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA.
    J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.
    Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, Macdiarmid SA.
    J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677
    [Abstract] [Full Text] [Related]

  • 5. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, Franco N, Bennett JB.
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [Abstract] [Full Text] [Related]

  • 6. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO.
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [Abstract] [Full Text] [Related]

  • 7. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U, Viterbo W, Bittencourt J, Farias T, Lordêlo P.
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder.
    Chen HW, Bercik RS, Werner EF, Thung SF.
    J Urol; 2012 Jan; 187(1):178-84. PubMed ID: 22100006
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy of percutaneous tibial nerve stimulation for different types of lower urinary tract dysfunction in children.
    Capitanucci ML, Camanni D, Demelas F, Mosiello G, Zaccara A, De Gennaro M.
    J Urol; 2009 Oct; 182(4 Suppl):2056-61. PubMed ID: 19695611
    [Abstract] [Full Text] [Related]

  • 10. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM, Eltabey NA, Wadie BS.
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [Abstract] [Full Text] [Related]

  • 12. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
    Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S.
    Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial.
    Finazzi-Agrò E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P.
    J Urol; 2010 Nov; 184(5):2001-6. PubMed ID: 20850833
    [Abstract] [Full Text] [Related]

  • 14. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O, Umek W, Laml T, Bjelic-Radisic V, Gabriel B, Mittlboeck M, Hanzal E.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [Abstract] [Full Text] [Related]

  • 15. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder.
    Tudor KI, Seth JH, Liechti MD, Ochulor J, Gonzales G, Haslam C, Fox Z, Pakzad M, Panicker JN.
    Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Percutaneous Tibial Nerve Stimulation for Overactive Bladder in Women and Men at a Safety Net Hospital.
    Jiang JF, Leung AK, Pettitt-Schieber B, Nabavizadeh R, Thomas RL, Brown M, Hafford D, Lay AH, Hammett J, Carney KJ, Filson CP, Master VA.
    J Urol; 2020 Feb; 203(2):385-391. PubMed ID: 31518202
    [Abstract] [Full Text] [Related]

  • 17. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, Ozden H, Ozisik Karaman H.
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F, van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL.
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [Abstract] [Full Text] [Related]

  • 19. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center.
    van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA.
    J Urol; 2017 Jul; 198(1):205-210. PubMed ID: 28189576
    [Abstract] [Full Text] [Related]

  • 20. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V, Guzmán R, Naser M, Aguilera A, Narvaez S, Castro A, Swift S, Digesu GA.
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.